The verdict was issued Dec. 9 in the U.S. Delaware District Court. Jurors found that four DePuy products — Zero-P VA, Zero-P, Zero-P Natural and SynFix Evolution — infringed RSB Spine’s patents. Jurors also found DePuy hadn’t proven that patent infringement claims were invalid.
The verdict concludes litigation that began with a lawsuit filed by RSB Spine Aug. 13, 2019. The lawsuit said the four DePuy products, used for spinal fusions, violated patents related to RSB Spine’s InterPlate devices.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
